Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 5 of 5 for “"RIT1"”.

  1. Protein-level regulation of oncogenic RIT1 in non-small cell lung cancer

    … mutation or amplification of the RAS-family gene RIT1, and RIT1 mutations do not co-occur with other canonical driver mutations. There is a growing understanding that the protein abundance of RIT1 is essential for its function. Therefore, inhibiting positive regulators of RIT1 abundance could be a …

    washington Repository record for Protein-level regulation of oncogenic RIT1 in non-small cell lung cancer (opens in a new tab)

  2. Mapping the molecular mechanism of GTPases KRAS and RIT1 in lung cancer

    … amongst the most important oncogenes. KRAS and RIT1 (Ras-like in all tissues) have been identified as cancer drivers in 30% and 2% of lung adenocarcinoma, respectively. RIT1 is traditionally studied using the homology between KRAS to inform functional mutations and effector proteins. Defining …

    washington Repository record for Mapping the molecular mechanism of GTPases KRAS and RIT1 in lung cancer (opens in a new tab)

  3. Structural Studies of Membrane-tethered KRAS4B Interaction with RAF and Inhibitors, and RIT1 Disease Mutants

    … the RAS-like wildly expressed in many tissues (RIT1) came to researchers' spotlight because of its etiologic role in Noonan Syndrome and cancer. Using a real-time NMR-based GTPase assay, we characterized the GTP hydrolysis and nucleotide exchange of RIT1 WT and five disease-associated mutants …

    toronto-retro Repository record for Structural Studies of Membrane-tethered KRAS4B Interaction with RAF and Inhibitors, and RIT1 Disease Mutants (opens in a new tab)

  4. Oncogene-driven post-transcriptional regulation in lung cancer

    … tumors. A gene of the same family, RIT1, is mutated or amplified in 10-15% of lung adenocarcinomas. Although therapies targeting some KRAS-mutated tumors have begun to enter the clinic, a comprehensive understanding of the Ras family and their regulatory functions continues to elude …

    washington Repository record for Oncogene-driven post-transcriptional regulation in lung cancer (opens in a new tab)

  5. Functional assessment of the RAS/MAPK pathway

    … using Western blots and flow cytometry in NF1, RIT1, and PTPN11 mutated fibroblasts and lymphoblasts. Although the mutated cell lines were expected to have higher levels of activation due to upregulation of the RAS/MAPK pathway, they were found to have decreased activation compared to the …

    bu Repository record for Functional assessment of the RAS/MAPK pathway (opens in a new tab)